Dr. E. Deforche · Checked.be

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Dr. E. Deforche is 0.2% (very low). The 2024 annual accounts show equity of €209k and a net result of €72k. Equity is growing by ~26.3% per year across the filed fiscal years. Its solvency ranks better than 34% of 6584 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Signals

2 signals · with evidence

Consistently profitable

Positive net result in the two most recent financial years (2023 and 2024).

View the result trend

Growing equity

Equity grew over 2022-2024. Profits are largely retained rather than distributed.

View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide

Deadline passed, not yet counted as missing

The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 19 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.

Filed after the deadline

The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-09-2025, 59 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.

How we compute the deadline

The year end is derived from 4 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	28-09-2025	59 d late	2025-00507764
31-12-2023	31-07-2024	08-10-2024	69 d late	2024-00502303
31-12-2022	31-07-2023	29-08-2023	29 d late	2023-00369337
31-12-2021	31-07-2022	02-09-2022	33 d late	2022-20402212

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

More than 3 years active

Founded in 2021, past the statistically most fragile first 3 years.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

0.2% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Young company +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€72k+1113.8%

Working capital€84k+1957.8%

CSV export

Annual accounts & ratios

Source: NBB · 2024

Annual accounts filed on 28-09-2025 with the NBB · fiscal year 2024 · micro

Operating resultNet result

Trajectory (indicative)

Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.

growing Equity: growth of ~26.3%/year over 4 fiscal years, indicative, assuming unchanged policy.

Solid line = filed figures · dashed = extended trend · area = indicative range.

How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison

Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	48.6%	66.7%	better than 34% of 6584 sector peers
Net result	€72k	€46k	better than 65% of 6578 sector peers
Equity	€209k	€79k	better than 80% of 6584 sector peers
Gross operating margin	€161k	€78k	better than 78% of 6586 sector peers
Staff costs	€20k	€21k	higher than 48% of 1212 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

Sector position over time

Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).

Solvency P34

Stable position over 2021-2024 · n=1848-6584

Net result P65

Weakening position over 2021-2024 · n=1848-6578

Equity P80

Stable position over 2021-2024 · n=1848-6584

Gross operating margin P78

Weakening position over 2021-2024 · n=1849-6586

Describes the position versus peers, not a forecast.

EBITDA

€141k

+157.3% 21-24

Net profit

€72k

+1113.8% 21-24

Cash flow

€111k

+143.6% 21-24

Total assets

€430k

+12.0% 21-24

Equity

€209k

+52.1% 21-24

Working capital

€84k

+1957.8% 21-24

Employees (FTE)

1

0.0% 21-24

Staff costs

€20k

+1.1% 21-24

Show 11 other metrics

Income taxes

€19k

+459.6% 21-24

Debt

€221k

-10.4% 21-24

Debt ≤ 1y

€125k

+3.3% 21-24

Debt > 1y

€96k

-23.5% 21-24

Current ratio

1.67

+61.8% 21-24

Quick ratio

1.67

+61.8% 21-24

Solvency

48.6%

+35.9% 21-24

Debt / equity

1.06

-41.1% 21-24

ROE

34.3%

+698.0% 21-24

ROA

16.6%

+984.2% 21-24

Interest coverage

12.81

+30.6% 21-24

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2024
Deposit	micro
Revenue	-
EBITDA	€141k
Net profit	€72k
Cash flow	€111k
Staff costs	€20k
Income taxes	€19k
Dividends	-
Total assets	€430k
Equity	€209k
Debt	€221k
of which ≤ 1y	€125k
of which > 1y	€96k
Working capital	€84k
Employees (FTE)	1.0

Ratios (computed)

	2024
Current ratio	1.67
Quick ratio	1.67
Working capital ratio	19.5%
Solvency	48.6%
Debt / equity	1.06
Long-term debt ratio	0.46
Interest coverage	12.81
Gross margin	-
Net margin	-
ROA	16.6%
ROE	34.3%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2024

Assets

Fixed assets €221k · 51.4% Current assets €209k · 48.6%

Equity & liabilities

Equity €209k · 48.6% Debt €221k · 51.4%

Full annual accounts (23 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€430k
Fixed assets	21/28	€221k
Intangible fixed assets	21	€188k
Tangible fixed assets	22/27	€33k
Current assets	29/58	€209k
Amounts receivable within one year	40/41	€21k
Cash & bank	54/58	€188k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€430k
Equity	10/15	€209k
Contributions / capital	10/11	€5k
Reserves	13	€204k
Amounts payable	17/49	€221k
Amounts payable after one year	17	€96k
Amounts payable within one year	42/48	€125k
Trade debts payable within one year	44	€977
Income statement
Gross operating margin	9900	€161k
Operating result	9901	€101k
Financial income	75	€412
Financial charges	65	€11k
Result before taxes	9903	€90k
Income taxes	67/77	€19k
Net result for the period	9904	€72k
Result to be appropriated	9905	€72k

This table shows the latest fiscal year. 3 prior years, with figures and ratios, belong to a paid plan. See plans →

Ratios computed by Checked.

Health barometer

FY 2024 · computed

94 / 100 Excellent

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register

exact location from the address register On OpenStreetMap

Establishment units

1 location

Huisartsenpraktijk Vier Seizoenen

Roeselarestraat 72, 8980 ZonnebekeActiviteiten van huisartspraktijken

since 20212.322.391.321

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels2

Ground area4,026 m²

Buildings2

Building footprint601 m²

Volume (LiDAR)2,391 m³

Tallest building10.9 m · ±2 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 2 (100%)